Clinical trial · Interventional
Weight Variation During Chemotherapy in Breast Cancer Patients
Weight Variation and Mechanisms Involved, During Chemotherapy in Breast Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Weight variation has been reported as a side effect of chemotherapy treatment in early breast cancer patients. To date, there is growing evidence for an increased risk of relapse and death in these patients who gain or lose weight. However, causes of weight variation during chemotherapy and mechanisms involved in the poor prognosis have been little studied. Thus, the investigators are conducting a prospective study to characterize weight variation in terms of body composition and to identify the mechanisms involved.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| blood test/ additional measurement | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- additional examinations/measurements
- interventionNames
- Other: blood test/ additional measurement
Primary outcomes (1)
- measure
- Change from baseline in body composition
- timeFrame
- within 2 weeks before chemotherapy; 1month after the last chemotherapy; and 6 months later.
Secondary outcomes (3)
- measure
- Change from baseline in energy balance
- timeFrame
- within 2 weeks before chemotherapy; 1month after the last chemotherapy; and 6 months later.
- description
- resting energy expenditure, physical activity, food records.
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * menopausal women * breast cancer * patients requiring chemotherapy treatment * WHO performance status 0-2 Exclusion Criteria: * diabetics * patients with metastases * other cancer
References
Publications (0)
Data not yet available